跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BLADITON FILM COATED TABLETS 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
BLADITON FILM COATED TABLETS 5MG
Approved
THERAPEUTIC
BLADITON FILM COATED TABLETS 5MG
SUN PHARMACEUTICAL INDUSTRIES LIMITED
🇸🇬 Health Sciences Authority
Approval Date
Sep 14, 2017
Approval ID
502133db73dcf512
Company
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Type
Therapeutic
Approval Details
Approval Id
502133db73dcf512
Drug Name
BLADITON FILM COATED TABLETS 5MG
Product Name
BLADITON FILM COATED TABLETS 5MG
Approval Number
SIN15331P
Approval Date
2017-09-14
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
G04BD08
Atc Item Name
solifenacin
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Solifenacin Succinate
5.00mg
SOLIFENACIN SUCCINATE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 14, 2017
Approval ID
502133db73dcf512
Type
Therapeutic
Back to HSA Approvals